In vitro experiments were undertaken to explore the potential role of CYP26B1 in bladder cancer (BLCA), utilizing MIBC (5637) and NMIBC (RT4) cell lines. The gene discussed is CYP26B1; the disease is bladder transitional cell carcinoma.